Studies involving amphetamines also suggest that GLP-1 receptor activation may reduce stimulant-related reward behaviors and hyperactivity, although no clinical trials for stimulant use disorder were identified in the review
In addition to the efficacy of GLP-1 for the treatment of diabetes mellitus and obesity, preliminary evidence indicates GLP-1s have neuroprotective, therapeutic, and disease modification effects for select neurodegenerative disorders (e.g
Anyone expecting meds to be included in a low-cost package
Common reasons why clients who come to see us have struggled in the past include lack of clarity as to the best diet for them, an underlying health issue, lack of self prioritisation or a dysfunctional relationship with food and eating (including non-hunger or emotional eating)
Marsh EE, Steinberg ML, Brandon Parker J, Ju W, Chakravarti D, Bulun SE
GLP-1 medications are reshaping medical weight loss, with Tirzepatide leading the current market while Retatrutide emerges as a promising new contender